<DOC>
	<DOCNO>NCT00975793</DOCNO>
	<brief_summary>The ARISE RCT multi-centre , randomise , control trial EGDT compare standard care patient severe sepsis present ED . The study conduct multiple site 1600 patient enrol study . Hypothesis test : EGDT , compare standard Australasian resuscitation practice , reduce 90-day all-cause mortality patient present ED severe sepsis .</brief_summary>
	<brief_title>Australasian Resuscitation In Sepsis Evaluation Randomised Controlled Trial</brief_title>
	<detailed_description>The primary aim study determine whether provide EGDT , compare standard care , reduce 90-day mortality patient present ED hospital Australasia severe sepsis . Each patient meeting exclusion criterion none exclusion criterion randomise ED receive either EGDT total 6 hour post-randomisation , standard care . Patients assign receive EGDT care dedicate ARISE study team . The patient receive treatment per study protocol 6 hour central blood oxygen level target end-point , receive standard care . Patients assign receive standard care continue care hospital team accordance current best practice . Patients group also receive additional treatment need , antibiotic surgery . This study involve 1600 patient severe sepsis admit ED multiple hospital .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<criteria>Suspected confirmed infection The presence TWO MORE follow SIRS criterion : Core temperature &lt; 36.0 degC &gt; 38.0 degC Heart rate &gt; 90 beats/minute Respiratory rate &gt; 20 breaths/minute PaCO2 &lt; 32 mmHg requirement mechanical ventilation acute process White blood cell count &gt; 12.0 &lt; 4.0 x109/L &gt; 10 % immature band form Evidence either refractory hypotension OR hypoperfusion : Refractory hypotension confirm presence systolic blood pressure ( SBP ) &lt; 90 mmHg mean arterial pressure ( MAP ) &lt; 65 mmHg 1000ml intravenous ( IV ) fluid challenge within 60 minute ( include IV fluid administer prehospital ) Hypoperfusion confirm presence blood lactate concentration great equal 4.0 mmol/L First dose IV antimicrobial therapy commence prior randomisation Age &lt; 18 year Contraindication superior vena cava ( SVC ) CVC insertion Contraindication blood product ( e.g . Jehovah 's Witness ) Inability commence delivery EGDT protocol within 1 hour randomisation complete 6 hour EGDT Haemodynamic instability due active bleeding Pregnancy ( confirm suspect ) Inpatient transfer another acute health care facility An underlying disease process life expectancy &lt; 90 day Death deem imminent inevitable A `` limitation therapy '' order document restrict implementation study protocol treat clinician deems aggressive care unsuitable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Sepsis</keyword>
	<keyword>Severe sepsis</keyword>
	<keyword>Septic shock</keyword>
</DOC>